Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10220213 | Gynecologic Oncology | 2018 | 8 Pages |
Abstract
Despite higher-stage disease and greater tumor burden, CGR rates, PFS and OS for patients who underwent PDS increased over a 13-year period. Surgical paradigm shifts implemented specifically to achieve more complete surgical cytoreduction are likely the reason for these improvements.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Jill H. Tseng, Renee A. Cowan, Qin Zhou, Alexia Iasonos, Maureen Byrne, Tracy Polcino, Clarissa Polen-De, Ginger J. Gardner, Yukio Sonoda, Oliver Zivanovic, Nadeem R. Abu-Rustum, Kara Long Roche, Dennis S. Chi,